Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion

Cited by (1,001)

Items 701–800 of 1,001

  1. The Landscape of Cancer Metabolism as a Therapeutic Target
    Kenji Ohshima · 2025 · Pathology International
  2. Tumor metabolome remolded by low dose mitochondrial uncoupler elicites robust CD8+ T cell response
    Xiaoxiao Jiang, Zhijin Fan, Zhenzhen Zhang, Fanchu Zeng, Tong Sheng Sun, Yuchen Li, Guojia Huang, Liming Nie · 2025 · Cell Death Discovery
  3. Glutamine metabolism and ammonia death: targeted modulation for enhanced cancer immunotherapy
    Fei Du, Linlin Xiao, Wang Guojun, Qian Dai, Junxin Li, Xin Zhao, Qimin Zhang, Lan Yang, Yujie Liu, Yidan Hu et al. · 2025 · Frontiers in Immunology
  4. “Dissecting the role of T cell exhaustion in cancer progression: a multifaceted approach“
    Xinyang Li, Shiwen Song · 2025 · Frontiers in Immunology
  5. Immune related biomarkers for cancer metastasis to the brain
    Weiwei Chen, Timothy Shun Man Chu, Liangliang Xu, Cai‐Ning Zhao, Wai Sang Poon, Gkk Leung, Feng‐Ming Kong · 2022 · Experimental Hematology and Oncology
  6. High-throughput in situ perturbation of metabolite levels in the tumor micro-environment reveals favorable metabolic condition for increased fitness of infiltrated T-cells
    Veronica Valvo, Elena Parietti, Kyle Deans, Sebastian W. Ahn, Noel R. Park, Benjamin Ferland, Devon Thompson, Christine A. Dominas, Sharath K. Bhagavatula, Shawn M. Davidson et al. · 2022 · Frontiers in Cell and Developmental Biology
  7. Metformin shows anti‐neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa‐associated aggressive cutaneous squamous cell carcinoma
    Tobias Welponer, Daniela D. Weber, Lisa Trattner, Birgit Tockner, Sepideh Aminzadeh-Gohari, V. Leb‐Reichl, Ariane Kaufmann, Roland Zauner, M. Wimmer, Verena Wally et al. · 2023 · Journal of the European Academy of Dermatology and Venereology
  8. Recent Advances in Polyoxometalate Based Nanoplatforms Mediated Reactive Oxygen Species Cancer Therapy
    Zhengya Yue, Runjie Wang, Jialun Li, Minglu Tang, Yang Li, Hao Gu, Xijin Wang, Tiedong Sun · 2023 · Chemistry - An Asian Journal
  9. DON of Hope: Starving Pancreatic Cancer by Glutamine Antagonism
    Ray Pillai, Thales Y. Papagiannakopoulos · 2023 · Cancer Research
  10. Cancer Metabolism under Limiting Oxygen Conditions
    Laura C. Kim, Nicholas P. Lesner, Marie Celeste Simon · 2023 · Cold Spring Harbor Perspectives in Medicine
  11. Oxygen and metabolic reprogramming in the tumor microenvironment influences metastasis homing
    Vinod Singh Bisht, Kuldeep Giri, Deepak Kumar, Kiran Ambatipudi · 2021 · Cancer Biology & Therapy
  12. Similarities and divergences in the metabolism of immune cells in cancer and helminthic infections
    Diego Esperante, Mónica Itzel Martínez-Gutiérrez, Mark E. Issa, Alejandro Schcolnik‐Cabrera, Fela Mendlovic · 2023 · Frontiers in Oncology
  13. DIMINISHED EXPRESSION OF GLS IN CD4+ T CELLS SERVES AS A PROGNOSTIC INDICATOR ASSOCIATED WITH CUPROPTOSIS IN SEPTIC PATIENTS
    Jiaqi Yang, Ning Chen, Pengyue Zhao, Xingpeng Yang, Yuxuan Li, Ze Fu, Yan Yang, Ning Dong, Songyan Li, Ren-qi Yao et al. · 2024 · Shock
  14. B cell trajectories influence cancer outcomes
    Julie Tellier, Stephen L. Nutt · 2024 · Science
  15. Glutamine Metabolism Heterogeneity in Glioblastoma Unveils an Innovative Combination Therapy Strategy
    Huangde Fu, Shengtian Wu, Hechun Shen, Kai Luo, Zhongxiang Huang, Nankun Lu, Yaolin Li, Lan Qian, Yishun Xian · 2024 · Journal of Molecular Neuroscience
  16. Targeting metabolic pathway enhance CAR-T potency for solid tumor
    Wenying Li, Jiannan Chen, Zhigang Guo · 2024 · International Immunopharmacology
  17. CircMFN2/miR-361-3p/ELK1 feedback loop promotes glutaminolysis and the progression of hepatocellular carcinoma
    Xiaopei Hao, Xiangjun Qian, Chenxi Xie, Zhengzheng Wang, Xiaoqian Wang, Yang Ji, Xiaokai Zhang, Qingjun Li, Baishun Wan, Hong Cui et al. · 2025 · Cancer Letters
  18. CRISPR/Cas9-mediated SHP-1-knockout T cells combined with simvastatin enhances anti-tumor activity in humanized-PDX HCC model
    Huaping Liu, Wu Ge, Xiaoping Yu, Jianwei Luo, Juan Zhang, Min Yang, Lu Cao, Yangnan Zhang, Ruike Wang, Cejun Yang et al. · 2025 · iScience
  19. Metabolic Regulation of T Cell Exhaustion
    Hao Wu, Miriam Campillo Prados, Martin Vaeth · 2025 · Immune discovery.
  20. Targeting Metabolic Reprogramming in Bladder Cancer Immunotherapy: A Precision Medicine Approach
    Fuyang Liu, Kai Li, Qingyi Zhu · 2025 · Biomedicines
  21. Cancer stem cells amino acid metabolism: Roles, mechanisms, and intervention strategies
    Yi Gong, Xirui Wang, Wenlong Chen, Hsiang‐i Tsai, Yanfang Liu · 2025 · Cellular Signalling
  22. Current Landscape of Preclinical Models for Pediatric Gliomas: Clinical Implications and Future Directions
    Syed Mohd Faisal, Monika Yadav, Garrett R. Gibson, Adora T. Klinestiver, Ryan M. Sorenson, Evan Cantor, Maria Ghishan, John R. Prensner, Andrea T. Franson, Kevin Fate Ginn et al. · 2025 · Cancers
  23. Inhibition of Glutamine Metabolism Attenuates Tumor Progression Through Remodeling of the Macrophage Immune Microenvironment
    Tianhe Li, Sepehr Akhtarkhavari, Sumeng Qi, Jiawei Fan, Tu‐Yung Chang, Yao Shen, Jinming Yang, Barbara Stauch Slusher, Ie‐Ming Shih, Stephanie L. Gaillard et al. · 2025 · Advanced Biology
  24. Dynamic remodeling of amino acid metabolism in tumor-associated macrophages: Fueling immunosuppression, reshaping tumor niches, and unlocking metabolic checkpoints
    Beibei Ran, Lingjun Xiao, Yan Liu, Chenglin Zhang, Lingkai Kong, Yuxin Zhang, Xiaosong Gu, Chunping Jiang, Junhua Wu · 2025 · Journal of Advanced Research
  25. The metabolic regulation of tumor-associated macrophage reprogramming
    Hao Fan, D. Lu, Xianyong Yin, Hao Sun, Zhihai Wang, Haohan Sun, Yuming Li, Yuming Li, Zijian Zhou, Liang Chen et al. · 2025 · Molecular Immunology
  26. Targeting Metabolic Reprogramming in Tumor: From Mechanisms to Precision Immunotherapies
    Tong Zhang, Ping Gao, Linchong Sun · 2025 · MedComm – Oncology
  27. The transcriptional repressor Fli1 inhibits proteostasis during nutrient stress to limit NK cell persistence in solid tumors
    Jeong Hyun Ji, Wesley Robert Armstrong, Joey H. Li, Areeba Lalani, Cassidy D. Lee, Varchas S. Bharadwaj, Kenneth Ho, Jingtong Liang, Alexander Muir, Timothy Edward O’Sullivan · 2026 · Immunity
  28. CDK8/CDK19 inhibition restores T-cell homeostasis in primary immune thrombocytopenia
    Yanming Wang, Hu Zhou, Shaoqiu Leng, Jun-Jie Ma, Hui-yuan Li, G. LI, Tao Sun, Yitong Xu, Shouqing Han, Yufeng Gu et al. · 2026 · Blood
  29. Hypoxia-driven metabolic heterogeneity and immune evasive behaviour of gastrointestinal cancers: Elements of a recipe for disaster
    Ashish Kumar Mishra, Siddharth Singh, Sruthilaya Dayanandan, Smaran Banerjee, Soumyadeep Chakraborty, Akshita Baiju Gopal, Supriya Samal, Indrajit Poirah, Debashish Chakraborty, Asima Bhattacharyya · 2022 · Cytokine
  30. Unlocking therapeutic potential: integration of drug repurposing and immunotherapy for various disease targeting.
    Vishakha Anand Pawar, Anuradha Tyagi, Chaitenya Verma, Kanti Prakash Sharma, Sekhu Ansari, Indra Mani, Shailesh Kumar Srivastva, Pradeep K. Shukla, Antresh Kumar, Vinay Kumar · 2023 · PubMed Central
  31. DON/DRP‐104 as potent serine protease inhibitors implicated in SARS‐CoV‐2 infection: Comparative binding modes with human TMPRSS2 and novel therapeutic approach
    Ernest Oduro‐Kwateng, Mahmoud E. S. Soliman · 2024 · Journal of Cellular Biochemistry
  32. Development of a prognostic model for muscle-invasive bladder cancer using glutamine metabolism
    Sida Hao, Lin Shen, Pengju Liu, Qin Yong, Yeqiang Wang, Xiangyi Zheng · 2024 · Computers in Biology and Medicine
  33. Glutamine metabolism prognostic index predicts tumour microenvironment characteristics and therapeutic efficacy in ovarian cancer
    Lingling Gao, Zheng Wei, Feiquan Ying, Lin Huang, Jingni Zhang, Si Sun, Zehua Wang, Jing Cai, Yuan Zhang · 2024 · Journal of Cellular and Molecular Medicine
  34. Principles of Personalized Oncology
    Kewal K. Jain · 2020 · Springer eBooks
  35. RNA Flow Cytometry for the Study of T Cell Metabolism
    Alessandra Rossi, Ilenia Pacella, Silvia Piconese · 2021 · International Journal of Molecular Sciences
  36. Administration of fusion cytokines induces tumor regression and systemic antitumor immunity
    Jinyu Zhang, Xuan Zhao · 2021 · MedComm
  37. Optimization of T Cell Redirecting Strategies: Obtaining Inspirations From Natural Process of T Cell Activation
    Yiyuan Gao, Yuedi Wang, Feifei Luo, Yiwei Chu · 2021 · Frontiers in Immunology
  38. Perspectives on immunometabolism at the biomaterials interface
    Sabrina L. Macias, Benjamin George Keselowsky · 2021 · Molecular Aspects of Medicine
  39. CD8+ T cell metabolic changes in breast cancer
    Ângela Castoldi, Jennifer Lee, Daniel de Siqueira Carvalho, Fabrício Oliveira Souto · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  40. Immune Cell Metabolism and Immuno-Oncology
    Chirag H. Patel, Jonathan D. Powell · 2023 · Annual Review of Cancer Biology
  41. Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors
    Zainab Fatima, Abdulrahman Abonofal, Bettzy Stephen · 2023 · Journal of Immunotherapy and Precision Oncology
  42. Combining single-cell and transcriptomic analysis revealed the immunomodulatory effect of GOT2 on a glutamine-dependent manner in cutaneous melanoma
    Lebin Song, Xiyi Wei, Xi Zhang, Yan Lu · 2023 · Frontiers in Pharmacology
  43. Multiplexed Single-cell Metabolic Profiles Organize the Spectrum of Cytotoxic Human T Cells
    Felix J. Hartmann, Dunja Mrdjen, Erin McCaffrey, David Richard Glass, Noah F. Greenwald, Anusha Bharadwaj, Zumana Khair, Alex Baranski, Reema Baskar, Michael Angelo et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  44. Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression
    Irene Flati, Mauro Di Vito Nolfi, Francesca Dall’Aglio, Davide Vecchiotti, Daniela Verzella, Edoardo Alesse, Daria Capece, Francesca Zazzeroni · 2023 · Genes
  45. Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer
    Guofeng Ma, Huiqing Jia, Zhiqiang Li, Xiangyan Zhang, Liping Wang, Zhilei Zhang, Yujing Xiao, Zhijuan Liang, Dan Li, Yuanbin Chen et al. · 2024 · Cancer Immunology Research
  46. DNAzyme-loaded bimetallic nanoflowers for STING activation and dual metabolic regulation to enhance antitumor immunity
    Jialing Guo, Ligang Wu, Chenxin Liu, Mei Yan, Chaoying Tian, Yingying Zhou, Xiaodi Zhang, Bin Du · 2024 · Chemical Engineering Journal
  47. IL17A/F secreted by ASCT2-overexpression ovarian cancer cells contributes to immune escape through the suppression of natural killer (NK) cells cytotoxicity by the activation of c-JUN/ PTGS2 pathway
    Huixiang Zhang, Haohan Li, Yanyan Qi, Junhan He, Li Deng, Shipu Chen, Hong Pan, Huiming Guo · 2025 · International Immunopharmacology
  48. Mn-coordination driven glutamine and cancer stemness dual-tailored nano-herb for high-efficiency activation of dendritic cells
    Fanchen Yan, Hailong Tian, Shanshan Liu, Jing Zhang, Chen Yang, Lihua Chen, Yaying Zhang, Yu Cao, Yunfeng Song, Canhua Huang et al. · 2025 · Biomaterials
  49. The role of deiodinases on metabolic alteration in cancer
    Caterina Miro, Annunziata Gaetana Cicatiello, Monica Dentice, Annarita Nappi · 2025 · Seminars in Cancer Biology
  50. Amino acids shape the metabolic and immunologic landscape in the tumor immune microenvironment: from molecular mechanisms to therapeutic strategies
    Ziyou Lin, Chang Chang, Shuyu Zhao, Lan Fang, Ping Wang · 2025 · Cancer Biology and Medicine
  51. ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalance
    Zhengnan Ming, Tiao Luo, Zizheng Zou, Wensong Luo, Xiyuan Hu, Ling Chen, Jiang Zhou, Xiaohe Liu, Liu Mingquan, Jijia Li et al. · 2025 · Hepatology Communications
  52. Intrinsic T cell glutaminolysis promotes autoimmunity in lupus-prone mice
    Seung‐Chul Choi, Yong Ge, Milind V. Joshi, Damian Jimenez, Abigail Castellanos Garcia, Cassandra LaPlante, Lauren T. Padilla, Chaoyu Ma, Nu Zhang, Jeffrey C. Rathmell et al. · 2025 · JCI Insight
  53. Immunometabolic Rewiring of Dendritic Cells to Overcome Glutamine‐Driven Immune Suppression in Colorectal Cancer
    Bingjie Zhang, Renming Fan, Yongrui Hai, Ye Chen, Xintong Lu, Wenhui Wang, Jiarui Dou, Jiaxin Yan, Chang Su, Yue Chen et al. · 2025 · Advanced Science
  54. Nutritional intervention alleviates T cell exhaustion and empowers anti-tumor immunity
    Yuqi Xu, Wenhui Yuan, Ke Li, Peng Li · 2025 · Frontiers in Immunology
  55. Tumor cell death by ferroptosis contributes to an immunosuppressive tumor microenvironment in syngeneic murine models of cancer
    Nneka E. Mbah, Damien Sutton, Hanna S. Hong, Rashi Singhal, Rosa Elena Menjivar, Matthew D. Perricone, Heather Giza, Peter Sajjakulnukit, Amy L. Myers, Zeribe C. Nwosu et al. · 2026 · Cancer & Metabolism
  56. Glutamine Antagonist GA-607 Causes a Dramatic Accumulation of FGAR which can be used to Monitor Target Engagement
    Jesse Alt, Sadakatali S. Gori, Kathryn M. Lemberg, Arindom Pal, Vijayabhaskar Veeravalli, Ying Wu, Joanna Marie H. Aguilar, Ranjeet Prasad Dash, Lukáš Tenora, Pavel Majer et al. · 2021 · Current Drug Metabolism
  57. Interrogation of T Cell–enriched Tumors Reveals Prognostic and Immunotherapeutic Implications of Polyamine Metabolism
    R. Alex Harbison, Rajeev Pandey, Michael Considine, Robert D. Leone, Tracy Murray Stewart, Rossin Erbe, Raj Mandal, Mark R. Burns, Robert A. Casero, Tanguy Y. Seiwert et al. · 2022 · Cancer Research Communications
  58. Glutamine antagonists may KEAP lung cancer in check
    Eliot B. Blatt, Ralph J. DeBerardinis · 2024 · Science Advances
  59. Causal effects of circulating glutamine on colitis, IBD, and digestive system cancers: a Mendelian randomisation study
    Yang Xie, Yonghui Wu, Qing Tao, Youxiang Chen, Chunyan Zeng · 2024 · Journal of Cancer
  60. Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act
    Jiske F. Tiersma, Bernard Evers, Barbara M. Bakker, Dirk‐Jan Reijngoud, Marco de Bruyn, Steven de Jong, Mathilde Jalving · 2024 · Cancer Treatment Reviews
  61. Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
    Sijin Sun, Yannan Yang, Zhenlin Yang, Juhong Wang, Renda Li, He Tian, Fengwei Tan, Qi Xue, Yibo Gao, Jie He · 2021 · Frontiers in Cell and Developmental Biology
  62. CTP sensing and Mec1ATR-Rad53CHK1/CHK2 mediate a two-layered response to inhibition of glutamine metabolism
    Arta Ajazi, Ramveer Choudhary, Laura Tronci, Angela Bachi, Christopher Bruhn · 2022 · PLoS Genetics
  63. Monitoring of Current Cancer Therapy by Positron Emission Tomography and Possible Role of Radiomics Assessment
    Noboru Oriuchi, Hideki Endoh, Kyoichi Kaira · 2022 · International Journal of Molecular Sciences
  64. Identification of fatty acid signature to predict prognosis and guide clinical therapy in patients with ovarian cancer
    Tiefeng Cao, Jiaqi Dong, Jiaming Huang, Zihao Tang, Huimin Shen · 2022 · Frontiers in Oncology
  65. Design, synthesis, and biological evaluation of novel glutaminase 1 allosteric inhibitors with an alkane chain tail group
    Xiujin Chang, Min Wang, Di Zhang, Yuqing Zhang, Jubo Wang, Zhiyu Li, Jinlei Bian, Xi Jin Xu · 2022 · European Journal of Medicinal Chemistry
  66. Labeling Assembly of Hydrophilic Methionine into Nanoparticle for Mild‐Heat Mediated Immunometabolic Therapy
    Xiao Wei Zheng, Ying Liu, Tingting Zhang, Yuge Zhao, Yiqiong Liu, Jie Zang, Gaowei Chong, Yan Li, Yushan Yang, Yan Gong Yang et al. · 2023 · Advanced Healthcare Materials
  67. Glutamine synthetase expression rescues human dendritic cell survival in a glutamine-deprived environment
    Robert Schoeppe, Nathalie Babl, Sonja-Maria Decking, Gabriele Schoenhammer, Andreas Siegmund, Christina Bruß, Katja Dettmer, Peter Josef Oefner, Linus Frick, Anna Weigert et al. · 2023 · Frontiers in Oncology
  68. Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets
    Zehua He, Qingfeng Chen, Wanrong He, Junyue Cao, Shunhan Yao, Qingqiang Huang, Yu Zheng · 2023 · Frontiers in Oncology
  69. Regulation of immune cell metabolism by cancer cell oncogenic mutations
    Alaa Madi, Guoliang Cui · 2020 · International Journal of Cancer
  70. Targeting Glutamine Metabolism and PD-L1: A Novel Anti-tumor Pas de Deux
    Maria I. Matias, Valérie Dardalhon, Naomi N. Taylor · 2020 · Molecular Cell
  71. Metabolic traits ruling the specificity of the immune response in different cancer types
    Nina C. Flerin, Federica Cappellesso, Samantha Pretto, Massimiliano Mazzone · 2020 · Current Opinion in Biotechnology
  72. Clonal Heterogeneity Supports Mitochondrial Metabolism in Pancreatic Cancer
    Christopher J. Halbrook, Galloway Thurston, Amy McCarthy, Barbara Scott Nelson, Peter Sajjakulnukit, Abigail S. Krall, Peter J. Mullen, Li Zhang, Sandeep Batra, Andrea Viale et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  73. Chemoproteomics Maps Glycolytic Targetome in Cancer Cells
    Yang Tian, Ning Wan, Ming Ding, Chang Shao, Nian Wang, Qiuyu Bao, Wenjie Lu, Hai Hu, Huiyong Sun, Chenxi Yang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Tumor-infiltrating regulatory T cell: A promising therapeutic target in tumor microenvironment
    Tianning Huang, Fan Li, Yiming Wang, Jian Gu, Ling Lü · 2024 · Chinese Medical Journal
  75. Natural products targeting the metabolism of amino acids: from discovery to synthetic development
    Hyun Su Kim, Ahmed H.E. Hassan, Kyuho Moon, Jaehoon Sim · 2025 · Natural Product Reports
  76. Bimetallic nanoadjuvant-mediated glutamine metabolism intervention and STING activation for enhanced antitumor immunity
    Jiashi Zhang, Chunzheng Yang, Jia Tan, Bin Liu, Zhuang Yang, Zhuangzhuang Li, Jie Ma, Meifang Wang, Binbin Ding, Abdulaziz Abdullah Al Kheraif et al. · 2025 · Nano Today
  77. From intracellular drivers to immune modulators: emerging paradigms in oncogenic pathway-directed immunotherapy optimization
    Dean Rao, Tiantian Wang, Chenan Fu, Yiming Luo, Junli Lu, Zhoubing Sun, Wei Yan, Huifang Liang, Limin Xia, Wenjie Huang · 2025 · Cell Communication and Signaling
  78. Mitochondrial glutamine import sustains electron transport chain integrity independently of glutaminolysis in cancer
    Lingzhi Zhu, Kuishen Wu, Jianwei You, Wen Mi, Jie Xu, Liucheng Li, Fang Yang, Xinyi Xia, Haohang Yan, Fei Li et al. · 2025 · Molecular Cell
  79. CAR-T Cell Exhaustion in Cancer over the Past Decade: Mitochondrial Metabolism as a Target for Counteraction
    Lingling Si, Di Wei, Jinghao Pan, Renato B. Baleeiro, Louisa S. Chard, Yaohe Wang · 2026 · Cancer Letters
  80. Lactylation of SLC26A3 in the acidic tumor microenvironment promotes malignant progression of colorectal carcinoma
    Chong Chen, Du Cai, Xuan-hui Liu, Yifan Zheng, Xinxin Huang, Dongwen Chen, JC Cai, Yiran Bie, Zhengran Zhou, Chuling Hu et al. · 2026 · Cell Death and Disease
  81. Can tumor cells take it all away?
    Anna Kohl, Kung‐Chi Kao, Ping‐Chih Ho · 2021 · Cell Metabolism
  82. Ulinastatin combined with glutamine improves liver function and inflammatory response in patients with severe acute pancreatitis.
    Li Zhao, Yanrong Ma, Qiuyue Li, Yuhan Wang · 2022 · PubMed Central
  83. Amino Acid Metabolism in Bone Metastatic Disease
    Deanna N. Edwards · 2023 · Current Osteoporosis Reports
  84. Chemical immunology: Recent advances in tool development and applications
    Yujie Shi, Eleanor E. Bashian, Yingqin Hou, Peng Wu · 2024 · Cell chemical biology
  85. Association of glutaminase expression with immune-suppressive tumor microenvironment, clinicopathologic features, and clinical outcomes in endometrial cancer
    Shiho Asaka, Neha Verma, Ting‐Tai Yen, Jessica L Hicks, Hirofumi Nonogaki, Yao Shen, Jiaxin Hong, Ryoichi Asaka, Angelo Michael De Marzo, Tian‐Li Wang et al. · 2024 · International Journal of Gynecological Cancer
  86. Agrimonia pilosa Extract suppresses NSCLC growth through regulating PI3K/AKT/Bcl-2 pathway
    Ze-Hua Tong, Wen-Jun Guo, Ya-Juan Xu, Yue Zhang, Wei-Fang Wang · 2025 · Journal of Ethnopharmacology
  87. Advances in the design and application of glycolysis-related nanodelivery systems for anti-tumor
    Yanghui Zhou, Meijing Liu, Na Lü, Xiangping Deng, Xin Chen, Lijing Tang, Zhizhong Xie, Xiaoyong Lei, Xiaoyan Yang, Saidong Zhou et al. · 2025 · Colloids and Surfaces B Biointerfaces
  88. Can natural selection and druggable targets synergize? Of nutrient scarcity, cancer, and the evolution of cooperation
    Neil W. Blackstone, Jordan U. Gutterman · 2020 · BioEssays
  89. Prognostic value of eight immune gene signatures in pancreatic cancer patients
    Wenting Wang, Zhijian Xu, Ning Wang, Ruyong Yao, Tao Qin, Hao Lin, Lu Yue · 2021 · BMC Medical Genomics
  90. Role of Metabolism in Adoptive T Cell Therapy: Strategies and Challenges
    Ge Hui Tan, Carmen Chak‐Lui Wong · 2022 · Antioxidants and Redox Signaling
  91. Microfluidic technologies in tumour metabolism
    Meabh Doherty, Tongchuan Wang, Dimitrios A. Lamprou, Jonathan A. Coulter · 2022 · International Journal of Pharmaceutics
  92. O-GlcNAcylation at the center of antitumor immunity
    Graham A. Heieis, Bart Everts · 2023 · Current Opinion in Biotechnology
  93. Identification and immune landscape analysis of fatty acid metabolism genes related subtypes of gastric cancer
    Rong Huang, Tailiang Lu, Rui Zhou · 2023 · Scientific Reports
  94. A facile and sensitive method of quantifying glutaminase binding to its inhibitor CB-839 in tissues
    Yicheng Chen, Yiqing Zhao, David Lawrence Bajor, Zhenghe Wang, Jennifer Eva Selfridge · 2020 · Journal of genetics and genomics/Journal of Genetics and Genomics
  95. Hyaluronic Acid Fuels Pancreatic Cancer Growth
    Peter K. Kim, Christopher J. Halbrook, Samuel A. Kerk, Stephanie Wisner, Daniel M. Kremer, Peter Sajjakulnukit, Sean W. Hou, Galloway Thurston, Abhinav Anand, Yan Liang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Identification of a novel prognostic model for gastric cancer utilizing glutamine-related genes
    Weidong Li, Qixing Zhong, Naisheng Deng, Haitao Wang, Jun Ouyang, Zhifen Guan, Xinhao Zhou, Kai Li, Xueying Sun, Yao Wang · 2024 · Heliyon
  97. T cell metabolism in kidney immune homeostasis
    Zikang Liu, Binbin Dai, Jiwen Bao, Yangbin Pan · 2024 · Frontiers in Immunology
  98. Mechanisms of T‑cell metabolic reprogramming in the microenvironment of acute myeloid leukemia and its therapeutic potential (Review)
    Yanhong Luo, Jie Luo, Min Jae Yang, Xueya Zhao · 2025 · Oncology Letters
  99. Breaking the vicious cycle: Multifunctional nanomaterials targeting Tumor metabolic reprogramming to overcome T cell exhaustion and bone repair failure in bone tumors
    Shijin Guo, Ziyi Yan, Yuling Huang, Xueneng Hu, Huaiyuan Zhang, Yu Wang, Tinglin Zhang, Huifen Qiang, Minghao Xue, Jie Gao et al. · 2025 · Materials Today Bio
  100. RNA methylation in hepatocellular carcinoma: from metabolic reprogramming and immune escape mechanisms to small molecule inhibitor development
    Yang Xu, Fei Lan, Chenguang Yang, Pengfei Li · 2025 · Journal of Translational Medicine